tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Novavax sees FY24 revenue $800M-$1.000B, consensus $969.56M

Sees FY24 Combined R&D and SG&A $700M-$800M.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on NVAX:

Disclaimer & DisclosureReport an Issue

1